• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Diagnostic performance and relationships of structural parameters and strain components for the diagnosis of cardiac amyloidosis with MRI.

作者信息

Zaarour Youssef, Sifaoui Islem, Remili Haifa, Kharoubi Mounira, Zaroui Amira, Damy Thibaud, Deux Jean-François

机构信息

Department of Radiology, Henri Mondor University Hospital, Assistance Publique-Hopitaux de Paris, 94000 Creteil, France.

Department of Radiology, Henri Mondor University Hospital, Assistance Publique-Hopitaux de Paris, 94000 Creteil, France.

出版信息

Diagn Interv Imaging. 2024 Dec;105(12):489-497. doi: 10.1016/j.diii.2024.08.002. Epub 2024 Sep 3.

DOI:10.1016/j.diii.2024.08.002
PMID:39232937
Abstract

PURPOSE

The purpose of this study was to evaluate the diagnostic performance and relationships of cardiac MRI structural parameters and strain components in patients with cardiac amyloidosis (CA) and to estimate the capabilities of these variables to discriminate between CA and non-amyloid cardiac hypertrophy (NACH).

MATERIALS AND METHODS

Seventy patients with CA (56 men; mean age, 76 ± 10 [standard deviation] years) and 32 patients (19 men; mean age, 63 ± 10 [standard deviation] years) with NACH underwent cardiac MRI. Feature tracking (FT) global longitudinal strain (GLS), radial strain (GRS), circumferential strain (GCS), strain AB ratio (apical strain divided by basal strain), myocardial T1, myocardial T2 and extracellular volume (ECV) were calculated. Comparisons between patients with CA and those with NACH were made using Mann-Whitney rank sum test. The ability of each variable to discriminate between CA and NACH was estimated using area under the receiver operating characteristic curve (AUC).

RESULTS

Patients with CA had higher median GLS (-7.0% [Q1, -9.0; Q3, -5.0]), higher median GCS (-12.0% [Q1, -15.0; Q3, -9.0]), and lower median GRS (16.5% [Q1, 13.0; Q3, 23.0]) than those with NACH (-9.0% [Q1, -11.0; Q3, -8.0]; -17.0% [Q1, -20.0; Q3, -14.0]; and 25.5% [Q1, 16.0; Q3, 31.5], respectively) (P < 0.001 for all). Median myocardial T1 and ECV were significantly higher in patients with CA (1112 ms [Q1, 1074; Q3, 1146] and 47% [Q1, 41; Q3, 55], respectively) than in those with NACH (1056 ms [Q1, 1011; Q3, 1071] and 28% [Q1, 26; Q3, 30], respectively) (P < 0.001). Basal ECV showed the best performance for the diagnosis of CA (AUC = 0.975; 95% confidence interval [CI]: 0.947-1). No differences in AUC were found between AB ratio of GRS (0.843; 95% CI: 0.768-0.918) and basal myocardial T1 (0.834; 95% CI: 0.741-0.928) for the diagnosis of CA (P = 0.81). The combination of the AB ratio of FT-GRS and basal myocardial T1 had a diagnostic performance not different from that of basal ECV (P = 0.06).

CONCLUSION

ECV outperforms FT-strain for the diagnosis of CA with cardiac MRI. The AB ratio of FT-GRS associated with myocardial T1 provides diagnostic performance similar to that achieved by ECV.

摘要

相似文献

1
Diagnostic performance and relationships of structural parameters and strain components for the diagnosis of cardiac amyloidosis with MRI.
Diagn Interv Imaging. 2024 Dec;105(12):489-497. doi: 10.1016/j.diii.2024.08.002. Epub 2024 Sep 3.
2
The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients.多参数心血管磁共振对肥厚型心肌病患者早期检测轻链淀粉样变性的诊断价值。
Front Cardiovasc Med. 2022 Oct 18;9:1017097. doi: 10.3389/fcvm.2022.1017097. eCollection 2022.
3
Regional Amyloid Burden Differences Evaluated Using Quantitative Cardiac MRI in Patients with Cardiac Amyloidosis.使用定量心脏磁共振成像评估心脏淀粉样变性患者的区域淀粉样蛋白负荷差异
Korean J Radiol. 2021 Jun;22(6):880-889. doi: 10.3348/kjr.2020.0579. Epub 2021 Feb 24.
4
Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping.利用心血管磁共振成像对心脏淀粉样变性和肥厚型心肌病的定量成像参数进行比较:反转时间预扫描与T1映射。
Int J Cardiovasc Imaging. 2018 Nov;34(11):1769-1777. doi: 10.1007/s10554-018-1385-2. Epub 2018 May 30.
5
CMR-based T1-mapping offers superior diagnostic value compared to longitudinal strain-based assessment of relative apical sparing in cardiac amyloidosis.CMR 技术的 T1 映射相对于基于纵向应变的相对心尖保留评估,对心脏淀粉样变性具有更高的诊断价值。
Sci Rep. 2021 Jul 30;11(1):15521. doi: 10.1038/s41598-021-94650-2.
6
3D myocardial deformation analysis from cine MRI as a marker of amyloid protein burden in cardiac amyloidosis: validation versus T1 mapping.基于心脏磁共振电影成像的三维心肌变形分析作为心脏淀粉样变性中淀粉样蛋白负荷的标志物:与T1映射的对比验证
Int J Cardiovasc Imaging. 2018 Dec;34(12):1937-1946. doi: 10.1007/s10554-018-1410-5. Epub 2018 Jul 16.
7
Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.新型心脏磁共振参数“心肌通过时间”(MyoTT)评估心脏淀粉样变和肥厚型心肌病微血管改变的诊断价值。
Clin Res Cardiol. 2021 Jan;110(1):136-145. doi: 10.1007/s00392-020-01661-6. Epub 2020 May 5.
8
Feasibility of Hepatic T1-Mapping and Extracellular Volume Quantification on Routine Cardiac Magnetic Resonance Imaging in Patients with Infiltrative and Systemic Disorders.浸润性和全身性疾病患者常规心脏磁共振成像中肝脏T1映射和细胞外容积定量的可行性
Acad Radiol. 2022 Apr;29 Suppl 4:S100-S109. doi: 10.1016/j.acra.2021.09.018. Epub 2021 Oct 23.
9
Diagnostic Value of Extracellular Volume Quantification and Myocardial Perfusion Analysis at CT in Cardiac Amyloidosis.心脏淀粉样变性的细胞外容积定量和心肌灌注分析的 CT 诊断价值。
Radiology. 2021 Aug;300(2):326-335. doi: 10.1148/radiol.2021204192. Epub 2021 Jun 8.
10
[Cardiac magnetic resonance-feature tracking technique can assess cardiac function and prognosis in patients with myocardial amyloidosis].心脏磁共振特征追踪技术可评估心肌淀粉样变性患者的心脏功能及预后
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Apr 20;43(4):660-666. doi: 10.12122/j.issn.1673-4254.2023.04.22.

引用本文的文献

1
Rapid progression of monoclonal gammopathy of undetermined significance to cardiac amyloidosis with intracardiac thrombus: Unveiling via cardiac magnetic resonance.意义未明的单克隆丙种球蛋白病快速进展为伴有心内血栓的心脏淀粉样变性:通过心脏磁共振揭示
Radiol Case Rep. 2025 Mar 8;20(5):2566-2571. doi: 10.1016/j.radcr.2025.02.022. eCollection 2025 May.